Dimitrios Loukopoulos. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » DeferiproneDeferoxamine/administration & dosageDrug Therapy, CombinationHumansIron Chelating Agents/administration & dosageIron Overload/bloodIron Overload/drug therapyPyridones/administration & dosagebeta-Thalassemia/bloodbeta-Thalassemia/drug therapy
Substances: See more » Iron Chelating AgentsPyridonesDeferiproneDeferoxamine
Year: 2005 PMID: 16219564
Source DB: PubMed Journal: Haematologica ISSN: 0390-6078 Impact factor: 9.941